{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:50:55Z","timestamp":1793904655612,"version":"4.8.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007273","name":"Medical College, Weill Cornell Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ymthe.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T18:20:14Z","timestamp":1730917214000},"page":"4303-4318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer\u2019s disease mice"],"prefix":"10.1016","volume":"32","author":[{"given":"Caner","family":"G\u00fcnaydin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolan","family":"Sondhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Kaminsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey C.","family":"Lephart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Leopold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R.","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richie","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-6839","authenticated-orcid":false,"given":"Ronald G.","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.11.003_bib1","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1073\/pnas.1601663113","article-title":"Genetic mutations you want","volume":"113","author":"Williams","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.003_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237122","article-title":"The protective mutation A673T in amyloid precursor protein gene decreases A\u03b2 peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells","volume":"15","author":"Guyon","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.11.003_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc9375","article-title":"APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.11.003_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147264","article-title":"Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer's disease","volume":"1753","author":"Owens","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.ymthe.2024.11.003_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41588-022-01280-z","article-title":"Notch1 mutations drive clonal expansion in normal esophageal epithelium but impair tumor growth","volume":"55","author":"Abby","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.11.003_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tibs.2019.03.009","article-title":"Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology","volume":"44","author":"Li","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ymthe.2024.11.003_bib7","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1038\/s41467-022-31686-6","article-title":"Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure","volume":"13","author":"Gerasimavicius","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.11.003_bib8","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/bloodadvances.2019000405","article-title":"Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants","volume":"5","author":"Samelson-Jones","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2024.11.003_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","article-title":"Apolipoprotein E: structure-function relationships","volume":"45","author":"Weisgraber","year":"1994","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.ymthe.2024.11.003_bib10","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/iub.1314","article-title":"Apolipoprotein E isoforms and lipoprotein metabolism","volume":"66","author":"Phillips","year":"2014","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ymthe.2024.11.003_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn0403-345","article-title":"Alzheimer's disease: the cholesterol connection","volume":"6","author":"Puglielli","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.003_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/nan.12529","article-title":"Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease","volume":"45","author":"Tzioras","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ymthe.2024.11.003_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219668","article-title":"The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE)","volume":"14","author":"Wolters","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.11.003_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-0358-9","article-title":"Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease","volume":"15","author":"Williams","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2024.11.003_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2024.11.003_bib16","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.003_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.11.003_bib18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.11.003_bib19","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.003_bib20","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2024.11.003_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4088\/JCP.v68n0419","article-title":"A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease","volume":"68","author":"Coon","year":"2007","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.ymthe.2024.11.003_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2024.11.003_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12031-016-0804-x","article-title":"The Neurobiology and Age-Related Prevalence of the epsilon4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts","volume":"60","author":"Heffernan","year":"2016","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.003_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.11.003_bib25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.11.003_bib26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3233\/JAD-180514","article-title":"Diffuse Amyloid-beta Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques","volume":"64","author":"Abner","year":"2018","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ymthe.2024.11.003_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102954","article-title":"Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank","volume":"59","author":"Lumsden","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2024.11.003_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.ymthe.2024.11.003_bib29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.11.003_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases","volume":"17","author":"Fern\u00e1ndez-Calle","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2024.11.003_bib31","article-title":"APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer\u2019s Disease pathology","author":"Chemparathy","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.ymthe.2024.11.003_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.1996.tb32597.x","article-title":"Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications","volume":"802","author":"Kaplitt","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ymthe.2024.11.003_bib33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1073\/pnas.0409072102","article-title":"Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease","volume":"102","author":"Dodart","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.003_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-015-0001-3","article-title":"Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice","volume":"10","author":"Hu","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2024.11.003_bib35","article-title":"APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease","author":"Jackson","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2024.11.003_bib36","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","article-title":"Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes","volume":"40","author":"Mahley","year":"1999","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.ymthe.2024.11.003_bib37","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.11.003_bib38","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jama.1997.03540340027028","article-title":"Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation","volume":"277","author":"Lopera","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2024.11.003_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1474-4422(10)70323-9","article-title":"Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study","volume":"10","author":"Acosta-Baena","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2024.11.003_bib40","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.neuron.2024.02.009","article-title":"Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer's disease profile and possible mechanisms of disease protection","volume":"112","author":"Almeida","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.ymthe.2024.11.003_bib41","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1056\/NEJMoa2308583","article-title":"APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer's Disease","volume":"390","author":"Quiroz","year":"2024","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.11.003_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biom12121792","article-title":"Heparan Sulfate Proteoglycans in Tauopathy","volume":"12","author":"Zhu","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2024.11.003_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/alz.13436","article-title":"APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation","volume":"20","author":"Marino","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ymthe.2024.11.003_bib44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-022-02467-8","article-title":"Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia","volume":"144","author":"Sepulveda-Falla","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2024.11.003_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13119","article-title":"Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection","volume":"33","author":"Henao-Restrepo","year":"2023","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2024.11.003_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202212636","article-title":"Apolipoprotein E Recognizes Alzheimer's Disease Associated 3-O Sulfation of Heparan Sulfate","volume":"62","author":"Mah","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ymthe.2024.11.003_bib47","article-title":"APOE3 Christchurch modulates tau phosphorylation and \u03b2-catenin\/Wnt\/Cadherin signaling in induced pluripotent stem cell-derived cerebral organoids from Alzheimer's cases","author":"Mazzarino","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2024.11.003_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2016.04.020","article-title":"Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models","volume":"44","author":"Zhao","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymthe.2024.11.003_bib49","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1074\/jbc.M411719200","article-title":"Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces","volume":"280","author":"Futamura","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.11.003_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-7-8","article-title":"Intraneuronal A\u03b2 detection in 5xFAD mice by a new A\u03b2-specific antibody","volume":"7","author":"Youmans","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2024.11.003_bib51","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1177\/002215540004800906","article-title":"X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology","volume":"48","author":"Styren","year":"2000","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.ymthe.2024.11.003_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103238","article-title":"Microglial transcription profiles in mouse and human are driven by APOE4 and sex","volume":"24","author":"Moser","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2024.11.003_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101594","article-title":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease","volume":"59","author":"Parhizkar","year":"2022","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.003_bib54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","article-title":"Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits","volume":"3","author":"Koutsodendris","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.ymthe.2024.11.003_bib55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fnagi.2018.00180","article-title":"APOE and Alzheimer's Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction","volume":"10","author":"Brandon","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.003_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbr.2013.03.021","article-title":"Impairment of nesting behaviour in 3xTg-AD mice","volume":"247","author":"Torres-Lista","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymthe.2024.11.003_bib57","series-title":"Pre-Clinical Models: Techniques and Protocols","first-page":"105","article-title":"The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice","author":"Kraeuter","year":"2019"},{"key":"10.1016\/j.ymthe.2024.11.003_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0149-7634(01)00041-0","article-title":"The neurobiological basis of spontaneous alternation","volume":"26","author":"Lalonde","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ymthe.2024.11.003_bib59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn. Process."},{"key":"10.1016\/j.ymthe.2024.11.003_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-018-1589-y","article-title":"Assessment of spatial learning and memory in the Barnes maze task in rodents-methodological consideration","volume":"392","author":"Gawel","year":"2019","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"10.1016\/j.ymthe.2024.11.003_bib61","article-title":"APOE \u03b54\/\u03b54 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline","volume":"6","author":"Abushakra","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ymthe.2024.11.003_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/genes10030222","article-title":"The Genetic Variability of APOE in Different Human Populations and Its Implications for Longevity","volume":"10","author":"Abondio","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2024.11.003_bib63","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/glia.23974","article-title":"Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation","volume":"69","author":"Lanfranco","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2024.11.003_bib64","first-page":"739","article-title":"ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease","volume":"42","author":"Jeong","year":"2019","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ymthe.2024.11.003_bib65","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2016.12.001","article-title":"ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease","volume":"28","author":"Lane-Donovan","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2024.11.003_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010778","article-title":"Apoe4 and Alzheimer's Disease Pathogenesis-Mitochondrial Deregulation and Targeted Therapeutic Strategies","volume":"24","author":"Pires","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.11.003_bib67","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1093\/brain\/awab478","article-title":"APOE4 derived from astrocytes leads to blood-brain barrier impairment","volume":"145","author":"Jackson","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2024.11.003_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111200","article-title":"APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-\u03baB activation","volume":"40","author":"Arnaud","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.11.003_bib69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13195-020-00712-4","article-title":"APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review","volume":"12","author":"Emrani","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ymthe.2024.11.003_bib70","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.003_bib71","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108870119","article-title":"Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation","volume":"119","author":"Saroja","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.003_bib72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2015.09.011","article-title":"Association of APOE with tau-tangle pathology with and without \u03b2-amyloid","volume":"37","author":"Farfel","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymthe.2024.11.003_bib73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-1-18","article-title":"Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons","volume":"1","author":"Hoe","year":"2006","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ymthe.2024.11.003_bib74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.11.003_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007000","article-title":"Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain","volume":"5","author":"Hudry","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.11.003_bib76","article-title":"Silencing of ApoE with Divalent siRNAs Drives Activation of Immune Clearance Pathways and Improves Amyloid Pathology in Mouse Models of Alzheimer\u2019s Disease","author":"Ferguson","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2024.11.003_bib77","article-title":"APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer's","volume":"22","author":"Yang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.11.003_bib78","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI113096","article-title":"Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia","volume":"80","author":"Wardell","year":"1987","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.11.003_bib79","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","article-title":"APOE3ch alters microglial response and suppresses A\u03b2-induced tau seeding and spread","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.11.003_bib80","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s41593-023-01480-8","article-title":"The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation","volume":"26","author":"Nelson","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.003_bib81","article-title":"APOE3-R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition","author":"Naguib","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2024.11.003_bib82","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/iep.12478","article-title":"Clinical applications of gene therapy for rare diseases: A review","volume":"104","author":"Papaioannou","year":"2023","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ymthe.2024.11.003_bib83","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymthe.2017.12.007","article-title":"Hyperactive Factor IX Padua: A Game-Changer for Hemophilia Gene Therapy","volume":"26","author":"VandenDriessche","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.11.003_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.792684","article-title":"The CCR5 Gene Edited CD34(+)CD90(+) Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy","volume":"13","author":"Karuppusamy","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.003_bib85","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/humc.2017.231","article-title":"AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease","volume":"29","author":"Rosenberg","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.11.003_bib86","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot102269","article-title":"Bradford Assay for Determining Protein Concentration","volume":"2020","author":"Kielkopf","year":"2020","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ymthe.2024.11.003_bib87","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1039\/D1CS00127B","article-title":"Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies","volume":"51","author":"Limorenko","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ymthe.2024.11.003_bib88","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20171265","article-title":"ApoE facilitates the microglial response to amyloid plaque pathology","volume":"215","author":"Ulrich","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.11.003_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212110","article-title":"Gray-level invariant Haralick texture features","volume":"14","author":"L\u00f6fstedt","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.11.003_bib90","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1038\/s41467-020-18046-y","article-title":"Steps towards standardized quantification of adult neurogenesis","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.11.003_bib91","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneumeth.2010.01.035","article-title":"The precision of video and photocell tracking systems and the elimination of tracking errors with infrared backlighting","volume":"188","author":"Bailoo","year":"2010","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.ymthe.2024.11.003_bib92","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3863","article-title":"Nestlet Shredding and Nest Building Tests to Assess Features of Psychiatric Disorders in Mice","volume":"10","author":"Dorninger","year":"2020","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.ymthe.2024.11.003_bib93","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnagi.2019.00335","article-title":"Early Cognitive and Behavioral Deficits in Mouse Models for Tauopathy and Alzheimer's Disease","volume":"11","author":"Samaey","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.003_bib94","article-title":"Novel Object Recognition Test for the Investigation of Learning and Memory in Mice","volume":"126","author":"Lueptow","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2024.11.003_bib95","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2744","article-title":"Barnes Maze Procedure for Spatial Learning and Memory in Mice","volume":"8","author":"Pitts","year":"2018","journal-title":"Bio. Protoc."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624007305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624007305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T03:19:21Z","timestamp":1764818361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624007305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":95,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1525001624007305"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.11.003","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in Alzheimer\u2019s disease mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}